Escalon Medical (OTCMKTS:ESMC) Announces Quarterly Earnings Results

Escalon Medical (OTCMKTS:ESMC) posted its quarterly earnings results on Friday. The medical equipment provider reported $0.16 earnings per share (EPS) for the quarter, reports. Escalon Medical had a negative net margin of 2.03% and a negative return on equity of 19.77%. The company had revenue of $2.61 million during the quarter.

Escalon Medical Stock Down 3.6%

OTCMKTS:ESMC opened at $0.25 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.65 and a quick ratio of 1.06. The company’s fifty day moving average price is $0.19 and its 200-day moving average price is $0.18. Escalon Medical has a 1-year low of $0.10 and a 1-year high of $0.46. The firm has a market capitalization of $1.86 million, a P/E ratio of 2.28 and a beta of 0.11.

Escalon Medical Company Profile

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea.